Drawing for EVEREST

USPTO serial 99103054

EVEREST

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
DUBRAY, KATHERINE M
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with EVEREST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa Greenwald-Swire

Lisa Greenwald-Swire Fish & Richardson P.C.P.O. Box 1022Minneapolis, MN 55440-1022United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for biological research, namely, analyzing DNA, nucleotides, enzymes, protein, amino acid sequences; Downloadable databases in the field of biological research, namely, DNA, nucleotides, enzymes, protein, amino acid sequences; Downloadable databases in the field of biostatistics for categorizing, sequencing, analyzing and annotating proteins, gene clusters, genomes and genomic features; Downloadable computer software for categorizing, sequencing, analyzing and annotating proteins, gene clusters, genomes and genomic features; Downloadable computer software for designing protein-based and genomic feature-containing products; Downloadable databases in the field of biodiscovery, namely, identifying plant and animal species from which to develop medicinal drugs; Downloadable databases in the field of bioprospecting, namely, identifying plant and animal species from which to develop medicinal drugs; Downloadable computer software for bioprospecting, namely, for use in categorizing data and drafting experiments for identifying plant and animal species from which to develop medicinal drugs; Downloadable computer software for biodiscovery, namely, for use in categorizing data and drafting experiments for identifying plant and animal species from which to develop medicinal drugs; Downloadable computer software for data analysis in the field of molecular designACTIVE—
035Data processing services; Services consisting of the registration, collection, transcription, compilation and systemization of written communications and data; Systematization of data in computer databases; Updating and maintenance of data in computer databases; Compiling of information into computer databases; all of the aforesaid data and information relating to DNA, genes, nucleotides, enzymes, proteins and amino acid sequences; Providing an on-line searchable database featuring referrals in the field of biological research of proteins, gene clusters, genomes and genomic feature-containing products; none of the aforesaid data and information relating to humans or human clinical trialsACTIVE—
042Software as a service (SAAS) services featuring software for analyzing biological data; Platform as a service (PAAS) featuring computer software platforms for analyzing biological data; Scientific and technological research services, namely, data analysis in the field of molecular design; Research and development in the field of molecular design; Providing scientific information in the field of molecular design; Data mining; Database design and development; Maintenance of on-line databases for others; all of the aforesaid services relating to DNA, genes, nucleotides, enzymes, proteins and amino acid sequences; Scientific and technological services, namely, bioprospecting in the field of plant and animal species from which medicinal drugs, biochemicals, and other commercially valuable material can be obtained; Development of new technology for others in the field of metagenomic sample preparation and sequencing; Development of new technology for others in the field of genomics and biotechnology; Research and development services in the field of genomics; Scientific and technological research services, namely, data analysis in the field of metagenomics; Research and development in the field of metagenomics; Scientific research in the field of metagenomics; Providing an on-line searchable database in the field of proteins, gene clusters, genomes and genomic feature-containing products for scientific research purposes; Providing an on-line searchable database in the field of biological research, namely, DNA, nucleotides, enzymes, protein, amino acid sequences for scientific research purposes; none of the aforesaid services relating to humans or human clinical trialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Jun 2, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 24, 2026DOCKASSIGNED TO EXAMINER—
Apr 7, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 7, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 1, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 16, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 23, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Feb 23, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 23, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 23, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 30, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 30, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 30, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 25, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Nov 25, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Aug 29, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 25, 2025DOCKASSIGNED TO EXAMINER—
Jul 10, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 25, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 25, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance